ApoCIII gene variants modulate postprandial response to both glucose and fat tolerance tests.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Circulation

• Publication date

  1999-04-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/01.CIR.99.14.1872PMID 10199885
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chylomicronemia due to apolipoprotein CIII overexpression in apolipoprotein E-null mice. Apolipoprotein CIII-induced hypertriglyceridemia is not mediated by effects on apolipoprotein E.

  1997cited by this paper
• The tissue-specific expression of lipoprotein lipase: implications for energy and lipoprotein metabolism.

  1997cited by this paper
• Apolipoprotein C-III gene variation and dyslipidaemia.

  1997cited by this paper
• The apolipoprotein A-I/C-III/A-IV gene cluster: ApoC-III and ApoA-IV expression is regulated by two common enhancers.

  1997cited by this paper
• Lipids, risk factors and ischaemic heart disease.

  1996cited by this paper
• New aspects on the role of plasma lipases in lipoprotein catabolism and atherosclerosis.

  1996cited by this paper
• Polymorphic markers in apolipoprotein C-III gene flanking regions and hypertriglyceridemia.

  1996cited by this paper
• Association of postprandial triglyceride and retinyl palmitate responses with asymptomatic carotid artery atherosclerosis in middle-aged men and women. The Atherosclerosis Risk in Communities (ARIC) Study.

  1995cited by this paper
• Association of postprandial triglyceride and retinyl palmitate responses with newly diagnosed exercise-induced myocardial ischemia in middle-aged men and women.

  1995cited by this paper
• Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia.

  1995cited by this paper
• Electrophoresis for genotyping: microtiter array diagonal gel electrophoresis on horizontal polyacrylamide gels, hydrolink, or agarose.

  1994cited by this paper
• In vivo regulation of lipolysis in humans.

  1994cited by this paper
• The European Atherosclerosis Research Study (EARS): design and objectives.

  1994cited by this paper
• Postprandial Triglyceride Response in Young Adult Men and Familial Risk for Coronary Atherosclerosis

  1994cited by this paper
• The distribution of fasting plasma lipid concentrations in the offspring of men with premature coronary heart disease in Europe. The EARS Study.

  1994cited by this paper
• Targeted disruption of the apolipoprotein C-III gene in mice results in hypotriglyceridemia and protection from postprandial hypertriglyceridemia.

  1994cited by this paper
• Demonstration of a critical role for free fatty acids in mediating counterregulatory stimulation of gluconeogenesis and suppression of glucose utilization in humans.

  1993cited by this paper
• Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles.

  1992cited by this paper
• Testing for association between disease and linked marker loci: a log-linear-model analysis.

  1991cited by this paper
• Variation at the apo AI/CIII/AIV gene complex is associated with elevated plasma levels of apo CIII.

  1991cited by this paper
• Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice.

  1990cited by this paper
• Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases.

  1989cited by this paper
• Effects of insulin on human adipose tissue metabolism in vivo.

  1989cited by this paper
• Molecular Evolutionary Genetics

  1987cited by this paper
• Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III.

  1985cited by this paper
• Apolipoprotein multigene family: tandem organization of human apolipoprotein AI, CIII, and AIV genes.

  1985cited by this paper
• Human Apolipoprotein A‐I‐C‐III Gene Complex is Located on Chromosome II

  1984cited by this paper
• The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus.

  1963cited by this paper

• Familial Combined Hyperlipidemia: Myth or Reality?

  2025cites this paper
• Increased Circulating Apolipoprotein Cs Are Implicated in the Association Between Elevated Serum Retinol and Retinol-Binding Protein 4 and Adverse Progression of Metabolic Syndrome in Adults: A Prospective Study.

  2025cites this paper
• FoxO6-mediated ApoC3 upregulation promotes hepatic steatosis and hyperlipidemia in aged rats fed a high-fat diet

  2024cites this paper
• Quantile-dependent expressivity of postprandial lipemia

  2020cites this paper
• APOC3 rs2070667 Associates with Serum Triglyceride Profile and Hepatic Inflammation in Nonalcoholic Fatty Liver Disease

  2020cites this paper
• The association between apolipoprotein A1-C3-A5 gene cluster promoter polymorphisms and risk of ischemic stroke in the northern Chinese Han population

  2017cites this paper
• Replication of association of the apolipoprotein A1-C3-A4 gene cluster with the risk of gout.

  2016cites this paper
• Apolipoprotein C3 Gene Variants and Risk of Developing Type 2 Diabetes in Saudi Subjects

  2015cites this paper
• Effect of apolipoprotein C3 genetic polymorphisms on serum lipid levels and the risk of intracerebral hemorrhage

  2015cites this paper
• Apolipoprotein C3 genetic polymorphisms are associated with lipids and coronary artery disease in a Chinese population

  2014cites this paper
• Fasting, non-fasting glucose and HDL dysfunction in risk of pre-diabetes, diabetes, and coronary disease in non-diabetic adults

  2013cites this paper
• Effect of non-esterified fatty acids on insulin resistance and cardiovascular risk in polycystic ovary syndrome

  2013cites this paper
• Age-Related Effects of Genetic Variation on Lipid Levels: The Columbia

  2013cites this paper
• Antecedents, characterisation and validity of cardiovascular disease biomarkers amongst South Asians in the UK

  2013cites this paper
• Postprandial Hypertriglyceridemia and Cardiovascular Disease: Current and Future Therapies

  2013cites this paper
• Cerebrovascular atherosclerosis in type III hyperlipidemia is modulated by variation in the Apolipoprotein A5 gene

  2011cites this paper
• Apolipoprotein CIII Overexpressing Mice Are Predisposed to Diet-Induced Hepatic Steatosis and Hepatic Insulin Resistance

  2011cites this paper
• Genetic Influences on Blood Lipids and Cardiovascular Disease Risk

  2011cites this paper
• Genetic variants and the metabolic syndrome: a systematic review

  2011cites this paper
• Association of an APOC3 promoter variant with type 2 diabetes risk and need for insulin treatment in lean persons

  2011influential citation
• APOA4 Polymorphism as a Risk Factor for Unfavorable Lipid Serum Profile and Depression

  2011cites this paper
• Influence of genetic variants in the apolipoprotein A5 and C3 gene on lipids, lipoproteins, and its association with coronary artery disease in Indians

  2010cites this paper
• Effect of apolipoprotein C3 and apolipoprotein A1 polymorphisms on postprandial response to a fat overload in metabolic syndrome patients.

  2010cites this paper
• Disturbance of apolipoprotein B100 containing lipoprotein metabolism in severe hyperlipidemic and lipodystrophic HIV patients on combined antiretroviral therapy: evidences of insulin resistance effect.

  2008cites this paper
• Apolipoprotein A5 gene −1131T/C polymorphism is associated with the risk of metabolic syndrome in ethnic Chinese in Taiwan

  2008cites this paper
• Polymorphisms in the APOA1/C3/A4/A5 gene cluster and cholesterol responsiveness to dietary change

  2007cites this paper
• Association of apolipoprotein A1-C3 gene cluster polymorphisms with gallstone disease.

  2007cites this paper
• APOC3 promoter polymorphisms C-482T and T-455C are associated with the metabolic syndrome.

  2007cites this paper
• Longitudinal analysis of haplotypes and polymorphisms of the APOA5 and APOC3 genes associated with variation in serum triglyceride levels: the Bogalusa Heart Study.

  2006cites this paper
• Associations between plasma lipid parameters and APOC3 and APOA4 genotypes in a healthy population are independent of dietary cholesterol intake.

  2006cites this paper
• Susceptibility to type 1 diabetes is associated with ApoCIII gene haplotypes.

  2006cites this paper
• Effect of SstI polymorphism of the apolipoprotein CIII gene and environmental factors on risks of hypertriglyceridemia in Taiwan aborigines.

  2006cites this paper
• Response to a urate-lowering diet according to polymorphisms in the apolipoprotein AI-CIII-AIV cluster.

  2005cites this paper
• Interaction between insulin (VNTR) and hepatic lipase (LIPC-514C>T) variants on the response to an oral glucose tolerance test in the EARSII group of young healthy men.

  2005cites this paper
• Variations in plasma apolipoprotein C-III levels are strong correlates of the triglyceride response to a high-monounsaturated fatty acid diet and a high-carbohydrate diet.

  2005cites this paper
• Relationship Bet ween the Polymorphism of Apolipoprotein C3 Gene - 482C > T and the Levels of Serum Lipids and Lipoproteins

  2005cites this paper
• The role and mode of action of apolipoproteins CIII and AV: synergistic actors in triglyceride metabolism?

  2004cites this paper
• Lipoprotein concentrations in newborns are associated with allelic variations in their mothers.

  2004cites this paper
• Rate of production of plasma and very-low-density lipoprotein (VLDL) apolipoprotein C-III is strongly related to the concentration and level of production of VLDL triglyceride in male subjects with different body weights and levels of insulin sensitivity.

  2004cites this paper
• Variation in USF1 shows haplotype effects, gene : gene and gene : environment associations with glucose and lipid parameters in the European Atherosclerosis Research Study II.

  2004cites this paper
• Isotretinoin and fenofibrate induce adiposity with distinct effect on metabolic profile in a rat model of the insulin resistance syndrome

  2004cites this paper
• Linkage and Association Between Distinct Variants of the APOA1/C3/A4/A5 Gene Cluster and Familial Combined Hyperlipidemia

  2004cites this paper
• Population prevalence of APOE, APOC3 and PPAR-α mutations associated to hypertriglyceridemia in French Canadians

  2004influential citation
• Genetic effect of two polymorphisms in the apolipoprotein A5 gene and apolipoprotein C3 gene on serum lipids and lipoproteins levels in a Chinese population

  2004cites this paper
• Contribution of polymorphisms in the apolipoprotein AI-CIII-AIV cluster to hyperlipidaemia in patients with gout

  2004cites this paper
• Apolipoprotein AIV Gene Variant S347 Is Associated With Increased Risk of Coronary Heart Disease and Lower Plasma Apolipoprotein AIV Levels

  2003cites this paper
• [Hypertriglyceridemia as a cardiovascular risk factor. The end of a controversy?].

  2003cites this paper
• The apolipoprotein CIII T2854G variants are associated with postprandial triacylglycerol concentrations in normolipidemic Korean men

  2003influential citation
• APOA5—a recent addition to genes determining plasma triglycerides

  2003cites this paper
• The Apolipoprotein AV Gene and Diurnal Triglyceridaemia in Normolipidaemic Subjects

  2003cites this paper
• Contribution of APOA5 gene variants to plasma triglyceride determination and to the response to both fat and glucose tolerance challenges.

  2003cites this paper
• Hipertrigliceridemia como factor de riesgo cardiovascular. ¿Fin de la controversia?

  2003cites this paper
• Coronary Heart Disease and Lower Plasma Apolipoprotein AIV Levels Apolipoprotein AIV Gene Variant S 347 Is Associated With Increased Risk of

  2003cites this paper
• associated with hypertriglyceridemia

  2003cites this paper
• A novel genetic variant in the apolipoprotein A5 gene is associated with hypertriglyceridemia.

  2003cites this paper
• Variants in the APOC3 promoter insulin responsive element modulate insulin secretion and lipids in middle-aged men.

  2003cites this paper
• Effect of apoC-III gene polymorphisms on the lipoprotein-lipid profile of viscerally obese men Published, JLR Papers in Press, February 16, 2003. DOI 10.1194/jlr.M300043-JLR200

  2003cites this paper
• Nutrient-Gene Interactions Obesity Risk Is Associated with Carbohydrate Intake in Women Carrying the Gln 27 Glu 2-Adrenoceptor Polymorphism

  2003cites this paper
• Obesity risk is associated with carbohydrate intake in women carrying the Gln27Glu beta2-adrenoceptor polymorphism.

  2003cites this paper
• Apolipoprotein and apolipoprotein receptor genes, blood lipids and disease

  2003cites this paper
• Clinical utility and approach to estimate postprandial hypertriglycemia by a newly designed oral fat-loading test.

  2003cites this paper
• Effect of apoC-III gene polymorphisms on the lipoprotein-lipid profile of viscerally obese men

  2003cites this paper
• Loci for CETP, LPL, LIPC, and APOC3 affect plasma lipoprotein size and sub-population distribution in Hispanic and non-Hispanic white subjects: the Columbia University BioMarkers Study.

  2002cites this paper
• ApoC-III gene polymorphisms and risk of coronary artery disease DOI 10.1194/jlr.M200145-JLR200

  2002cites this paper
• Gene nutrient interactions in type 2 diabetes--a clinical perspective.

  2002cites this paper
• Genetic determinants of the response to bezafibrate treatment in the lower extremity arterial disease event reduction (LEADER) trial.

  2002cites this paper
• Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides.

  2002cites this paper
• Apolipoprotein C‐III and E Polymorphisms and Cardiovascular Syndrome, Hyperlipidemia, and Insulin Resistance in Renal Transplantation

  2002cites this paper
• Influence of the APOC3 -2854T>G polymorphism on plasma lipid levels: effect of age and gender.

  2002cites this paper
• APOLIPOPROTEIN AIV GENE VARIANT S 347 IS ASSOCIATED WITH INCREASED RISK OF CORONARY HEART DISEASE AND LOWER APOLIPOPROTEIN AIV PLASMA CONCENTRATIONS Submission Type : Original Contribution

  2002cites this paper
• Linkage and association of haplotypes at the APOA1/C3/A4/A5 gene cluster to familial combined hyperlipidemia

  2002cites this paper
• Linkage and association of haplotypes at the APOA1/C3/A4/A5 genecluster to familial combined hyperlipidemia

  2002cites this paper
• Linkage and Association of Haplotypes at the APOA 1 / C 3 / A 4 / A 5 Gene Cluster to Familial Combined Hyperlipidemia

  2002cites this paper
• Associations of LPL and APOC3 gene polymorphisms on plasma lipids in a Mediterranean population: interaction with tobacco smoking and the APOE locus.

  2002cites this paper
• ASSOCIATED WITH INCREASED RISK OF

  2002cites this paper
• Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism

  2001cites this paper
• CHAPTER 11 – Genetic Influences on Blood Lipids and Cardiovascular Disease Risk

  2001cites this paper
• Candidate Gene Polymorphism in Cardiovascular Disease: A Comparative Study of Frequencies between a French and an Italian Population

  2001cites this paper
• Effect of genetic variation on the postprandial response. Results from the European Atherosclerosis Research Study II.

  2001cites this paper
• An interaction between apo C-III variants and protease inhibitors contributes to high triglyceride/low HDL levels in treated HIV patients

  2001cites this paper
• Interaction of the common apolipoprotein C-III (APOC3 -482C > T) and hepatic lipase (LIPC -514C > T) promoter variants affects glucose tolerance in young adults. European Atherosclerosis Research Study II (EARS-II).

  2001cites this paper
• Age-related effects of genetic variation on lipid levels: The Columbia University BioMarkers Study.

  2001influential citation
• Genetic heterogeneity in the apolipoprotein C-III promoter and effects of insulin.

  2001cites this paper
• The apoAI-CIII-AIV gene cluster.

  2001cites this paper
• Interaction of the common apolipoprotein C‐III (APOC3 ‐482C > T) and hepatic lipase (LIPC ‐514C > T) promoter variants affects glucose tolerance in young adults. European Atherosclerosis Research Study II (EARS‐II)

  2001cites this paper
• Prevalence of the APOC3 promoter polymorphisms T-455C and C-482T in Asian-Indians.

  2001cites this paper
• Genetic determination of plasma lipids and insulin in the Czech population.

  2001cites this paper
• Variable effects of the APOC3 –482C > T variant on insulin, glucose and triglyceride concentrations in different ethnic groups

  2001cites this paper
• Genetic determinants of plasma triglycerides: Impact of rare and common mutations

  2001cites this paper
• Two newly identified SNPs in the APO AI‐CIII intergenic region are strongly associated with familial combined hyperlipidaemia

  2001cites this paper
• Therapeutic considerations for postprandial dyslipidaemia

  2001cites this paper
• Postprandial lipemia and coronary risk

  2000cites this paper
• Contribution of Apolipoprotein C-III Gene Variants to Determination of Triglyceride Levels and Interaction With Smoking in Middle-Aged Men

  2000cites this paper
• In-vivo and in-vitro nutrient-gene interactions.

  2000cites this paper
• The Impact of Postprandial Lipemia in Accelerating Atherothrombosis

  2000cites this paper
• Genetic determinants of plasma lipid response to dietary intervention: the role of the APOA1/C3/A4 gene cluster and the APOE gene

  2000cites this paper
• Plasma levels of remnant particles are determined in part by variation in the APOC3 gene insulin response element and the APOCI-APOE cluster.

  2000cites this paper
• The Pro12Ala polymorphism in the peroxisome proliferator-activated receptor γ2 gene is not associated with postprandial responses to glucose or fat tolerance tests in young healthy subjects: the European Atherosclerosis Research Study II

  2000cites this paper
• Characterization of the lipid-binding properties and lipoprotein lipase inhibition of a novel apolipoprotein C-III variant Ala23Thr.

  2000cites this paper
• Postprandial response to a fat tolerance test in young adults with a paternal history of premature coronary heart disease — the EARS II study

  2000cites this paper